This is achieved may be due to the ability of these SMOFlipid plus ApoA-II to circulate with long half-lives (2–4.5 days) (Fig 4, [48, 49]), enabling them repeated passages through blood vessels feeding growing tumor. Here, APOA2 is linked to neoplasm.